✦ LIBER ✦

Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by Editta Baldini; Andrea Ardizzoni; Tiziana Prochilo; Maria A. Cafferata; Luca Boni; Carmelo Tibaldi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine, ifosfamide and paclitaxel i

✍ F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 206 KB

Effects of gemcitabine on cell prolifera

✍ E. Pace; M. Melis; L. Siena; F. Bucchieri; A. M. Vignola; M. Profita; M. Gjomark 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 337 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Paclitaxel and gemcitabine combination i

✍ Athanasios Athanasiadis; George Roussos; Thomas Papakostoulis; Daniela-Carmen At 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 197 KB

Gemcitabine pharmacokinetics and interac

✍ Stacy S. Shord; Stephanie R. Faucette; Heidi H. Gillenwater; Scott L. Pescatore; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

A phase II study of ifosfamide and a2b-i

✍ M. J. Lind; S. Gomm; A. P. Simmonds; L. Ashcroft; A. Kamthan; H. Gurney; N. That 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 295 KB